Wildlife Health Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Wildlife Health Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

The global wildlife health market was valued at USD 2.3 billion in 2023 and is projected to grow at a CAGR of 8.9% from 2024 to 2032. This growth is driven by increased awareness of zoonotic diseases, which can spread between animals and humans. Urbanization, deforestation, and climate change have intensified human-wildlife interactions, raising global awareness of wildlife health. For instance, in October 2023, Oregon State University researchers, under a U.S. Department of Agriculture agreement, tested around 1,600 wild animal specimens for SARS-CoV-2 to identify species that can harbor and transmit the virus. This initiative highlights the importance of monitoring and managing wildlife health to prevent disease transmission. Government bodies and health agencies are investing in wildlife health initiatives, boosting demand for veterinary services, diagnostic tools, and research.

The overall wildlife health industry is classified based on the species, products and services, medical devices, end-user, and region.

The market categorizes species into mammals, birds, fish, reptiles, and amphibians. The mammals segment led the market in 2023 with USD 1 billion in revenue and is expected to maintain its dominance with a CAGR of 8.8%. Mammals play a crucial role in ecosystems and zoonotic disease transmission, making them central to wildlife health studies. Their complex physiology and diverse habitats necessitate focused research and monitoring to manage and prevent disease outbreaks, protect biodiversity, and ensure public health.

The market classifies products and services into pharmaceuticals, medical devices, and veterinary services. In 2023, the pharmaceuticals segment held a 46.8% market share and is expected to remain dominant. This segment includes drugs, vaccines, and medical additives, essential for managing and treating diseases across various wildlife species. The demand for effective treatments and preventive measures, along with innovations in veterinary medicine, drives the market's growth. Additionally, increasing awareness of zoonotic diseases and the need for robust disease management in wildlife conservation efforts further contribute to the expansion of the pharmaceuticals segment.

In 2023, the U.S. accounted for USD 921.3 million of the North American wildlife health market and is expected to grow significantly. The U.S. leads the market due to its extensive resources, advanced research capabilities, and substantial investments from federal agencies like the U.S. Fish and Wildlife Service and the CDC. The country also benefits from a robust network of veterinary institutions dedicated to wildlife welfare. The U.S.'s strong infrastructure for monitoring, disease management, and conservation efforts positions it as a leader in addressing wildlife health challenges and advancing the market.